These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC J Am Soc Nephrol; 2004 Oct; 15(10):2735-46. PubMed ID: 15466279 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients. Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial. Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW; Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790 [TBL] [Abstract][Full Text] [Related]
12. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis. Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol. Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K; Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900 [TBL] [Abstract][Full Text] [Related]
14. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial. Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836 [TBL] [Abstract][Full Text] [Related]
15. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Ritzau J; Hoffman RM; Tzamaloukas AH Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831 [TBL] [Abstract][Full Text] [Related]
16. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Xu G; Tu W; Xu C Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557 [TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. McCann M; Moore ZE Cochrane Database Syst Rev; 2010 Jan; (1):CD006894. PubMed ID: 20091610 [TBL] [Abstract][Full Text] [Related]
18. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. Davenport A; J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Jassal SV; Lok CE; Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950 [TBL] [Abstract][Full Text] [Related]